Promotes physiological immune defenses.

• Cordyceps sinensis mycelium
• EGCG purified extract of green tea leaves
• Blend of Betaglucans extracted from:
  • Agaricus Blazei
  • Cordyceps sinensis
  • Ganoderma lucidum
  • Grifola frondosa
  • Lentinula edodes
• tit. 30% Total polysaccharides
• tit. 15% 1,3-1,6 Betaglucans
• vegetable capsules

One capsule 2 times a day with plenty of water

Pack of 70 vegetable capsules

• store in a cool, dry place
• listed in the supplement register: code 49911
• Paraf code: A924519681

1. Hobbs, C. Medicinal Mushrooms: An Exploration of Tradition, Healing, and Culture. Santa Cruz, CA: Botanica Press, 1986.2. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspective (review) S.Wasser, L.Weis. International Journal of Medicinal Mushrooms Vol.1,31-62 (1999)
2. Kidd PM The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev 2000 Feb;5(1):4-27
3. Wasser, S.P. “Review of Medicinal Mushroom Advances: Good News from Old Allies.” HerbalGram 56 (2002): 28–33.
4. Medicinal mushrooms as a source of antitumor and immunomodulating polysaccharides S.P. Wasser Appl Microbiol Biotechnol (2002) 60:258–274 DOI 10.1007/s00253-002-1076-7
5. Lindequist U, Niedermeyer T. H. J., Jülich W.D. The Pharmacological Potential of Mushrooms eCAM 2005 2(3):285-299; doi:10.1093/ecam/neh107
6. Oral Delivery and Gastrointestinal Absorption of Soluble Glucans Stimulate Increased Resistance to Infectious Challenge Peter J. Rice, Elizabeth L. Adams, Tammy Ozment-Skelton, Andres J. Gonzalez, Matthew P. Goldman
7. Clinical Trial report on treatment of chronic Hepatitis B using Immune-Assist™ brand Dietary Supplement as adjunct with lamivudine [EPIVIR™] . Wang Ruwei et al. http://www.alohamedicinals.com/Hep_B_Study2.htm
8. Andrea T. Borchers, Anita Krishnamurthy, Carl L. Keen, Frederick J. Meyers, and M. Eric Gershwin The Immunobiology of Mushrooms Exp Biol Med, Mar 2008; 233: 259 – 276.
9. The effects of whole mushrooms during inflammation Keith R Martin, Sanhong Yu, Veronika Weaver, and Margherita Cantorna FASEB J, Apr 2009; 23: LB522
10. Immunological effects of yeast- and mushroom-derived beta-glucans. V Vetvicka, A Vashishta, S Saraswat-Ohri, and J Vetvickova J Med Food, Dec 2008; 11(4): 615-22.
11. Effects of beta-glucans on the immune system. D Akramiene, A Kondrotas, J Didziapetriene, and E Kevelaitis Medicina (Kaunas), Jan 2007; 43(8): 597-606.
12. Potential of the beta-glucans to enhance innate resistance to biological agents. IJ Thompson, PC Oyston, and DE Williamson Expert Rev Anti Infect Ther, Mar 2010; 8(3): 339-52
13. beta-Glucans in promoting health: prevention against mutation and cancer. MS Mantovani, MF Bellini, JP Angeli, RJ Oliveira, AF Silva, and LR Ribeiro Mutat Res, Mar 2008; 658(3): 154-61.
14. Beta-glucans in higher fungi and their health effects. O Rop, J Mlcek, and T Jurikova Nutr Rev, Nov 2009; 67(11): 624-31.
15. The biological activity of beta-glucans M Rondanelli, A Opizzi, and F Monteferrario Minerva Med, Jun 2009; 100(3): 237-45.
16. The main green tea polyphenol epigallocatechin-3-gallate counteracts semen-mediated enhancement of HIV infection Ilona Hauber, Heinrich Hohenberg, Barbara Holstermann, Werner Hunstein, and Joachim Hauber PNAS, Jun 2009; 106: 9033 – 9038
17. Epigallocatechin Gallate Inactivates Clinical Isolates of Herpes Simplex Virus Charles E. Isaacs, Guang Y. Wen, Weimin Xu, Jun Hua Jia, Lisa Rohan, Christopher Corbo, Vincenzo Di Maggio, Edmund C. Jenkins, Jr., and Sharon Hillier Antimicrob. Agents Chemother., Mar 2008; 52: 962 – 970.
18. Inhibition of HIV-1 infectivity across subtypes by the green tea catechin, epigallocatechin gallate, without altered immune function Christina L Nance, Edward B Siwak, Melinda D’Souza, Sonia Songa, Ashley M McMullen, and William T Shearer J. Immunol., Apr 2009; 182: 128.6.
19. Inhibitory effects of (-)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). K Yamaguchi, M Honda, H Ikigai, Y Hara, and T Shimamura. Antiviral Res, Jan 2002; 53(1): 19-34.